ISOL Q2 nearly the same as AURORA CANNABIS (ACB)
To put things in perspective for everyone, ISOL only did a $100 Grand less than ACB did this Q2.
$ACBFF is trading at $2.95 a share and they actually have WAY more Shares out than $ISOLF . Plus $ISOLF has a much lower monthly burn rate than $ACBFF .
This graph below needs to be updated being that $ISOLF should be showing a $5.1 Million Q2 but it gives you a very good understanding of where $ISOLF is heading in the near future IMHO.
Also here's this am's news for those of you who missed it.
Mr. Marcos Agramont reports
ISODIOL INTERNATIONAL PROVIDES CORPORATE UPDATE
Isodiol International Inc. has released the fiscal 2018 second quarter revenues of its wholly owned subsidiary, ISO International LLC: $4.07-million (U.S.) ($5.1-million) compared with fiscal 2018 first quarter revenues of $3.92-million (U.S.) ($4.92-million).
Isodiol International chief executive officer, Marcos Agramont, stated: "Over the last quarter, we have expanded our footprint in Brazil and more recently our operations into Chile. We will continue to push our international expansion strategy by developing the European and Asian markets for our consumer products while working with local health authorities for medical approval of our flagship product, Isoderm. We had another strong quarter of revenue growth and will continue our commitment to delivering high-quality hemp-derived CBD [cannabidiol] products through innovative delivery methods, which is the core of our success."
About Isodiol International Inc.
Isodiol International is the market leader in pharmaceutical- and nutraceutical-grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of plus-99-per-cent-pure, bioactive pharmaceutical-grade cannabinoids, microencapsulations and nanotechnology for the highest-quality consumable and topical skin care products.
We seek Safe Harbor.
